A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors ...

In patients with type 2 diabetes (T2D), the risks for gastroesophageal reflux disease (GERD) and GERD-related complications were greater with GLP-1 receptor agonist (RA) use than with SGLT2 inhibitor ...

The diagnosis and optimal treatment of the extraesophageal complications of gastroesophageal reflux disease (GERD) have been long-standing topics in evolution. A decade ago, it was believed that ...

July 14 (UPI) --Folks using GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, a new study says. People with type 2 diabetes were more likely to suffer from ...

Acid reflux is when stomach acid flows into the esophagus and mouth, causing heartburn. GERD is a chronic form of acid reflux, and it can lead to serious health problems if untreated. Triggers of GERD ...

A 39-year-old's heart paused for 15 seconds during a blood draw, and he needed chest compressions. He had fainted during a blood draw once before. A Man Came In for Swollen Feet and a Foot Wound, and ...

The diagnosis of GERD varies based on patient symptoms and may include upper endoscopy or reflux testing. Communication with PCPs helps improve patient care and provides opportunity for education. The ...

As many as one in five people suffer from Gastroesophageal Reflux Disease, also known as GERD, but they might not know it. Jessica Stout, DO, a gastroenterologist at University of Utah Health, ...

No evidence supports a significant link between gastroesophageal reflux disease (GERD) and pancreatitis. However, they share some risk factors, such as excessive alcohol consumption and obesity.